Procalcitonin-guided use of antibiotic in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease: a randomized clinical trial

This publication has 22 references indexed in Scilit:

• Procalcitonin for Antibiotic Prescription in Chronic Obstructive Pulmonary Disease Exacerbations: Systematic Review, Meta-Analysis, and Clinical Perspective
  Pulmonary Therapy, 2020
• C-Reactive Protein Testing to Guide Antibiotic Prescribing for COPD Exacerbations
  New England Journal of Medicine, 2019
• Procalcitonin-Guided Use of Antibiotics for Lower Respiratory Tract Infection
  New England Journal of Medicine, 2018
• Acute exacerbations of chronic obstructive pulmonary disease with low serum procalcitonin values do not benefit from antibiotic treatment: a prospective randomized controlled trial
  International Journal of Infectious Diseases, 2016
• Sputum colour reported by patients is not a reliable marker of the presence of bacteria in acute exacerbations of chronic obstructive pulmonary disease
  Clinical Microbiology and Infection, 2010
• Effect of Procalcitonin-Based Guidelines vs Standard Guidelines on Antibiotic Use in Lower Respiratory Tract Infections
  JAMA, 2009
• Antibiotic treatment interruption of suspected lower respiratory tract infections based on a single procalcitonin measurement at hospital admission—a randomized trial
  Clinical Microbiology and Infection, 2009
• Relation of sputum colour to bacterial load in acute exacerbations of COPD
  Respiratory Medicine, 2009
• Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial
  The Lancet, 2004
• Evaluation of New Anti-Infective Drugs for the Treatment of Respiratory Tract Infections
  Clinical Infectious Diseases, 1992